Novartis Venture Fund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
12
- Investments
-
348
- Portfolio
-
48
- Exits
-
169
Novartis Venture Fund General Information
Company Description
Founded in 1996, Novartis Venture Fund is a corporate venture capital arm of Novartis based in Basel, Switzerland. The firm seeks to invest in the life sciences, oncology, biotechnology, and digital health sectors.
Business Details
Website
www.nvfund.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- Postfach
- 4002 Basel
- Switzerland
Novartis Venture Fund Investments (348)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Alesta Therapeutics | 19-Dec-2024 | Early Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| Citryll | 09-Dec-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Rhygaze | 05-Dec-2024 | Therapeutic Devices | Pre-Clinical Trials | |||
| Hyku | 12-Nov-2024 | Biotechnology | Startup | |||
| LoQus23 Therapeutics | 02-Oct-2024 | Biotechnology | Pre-Clinical Trials | |||
| ONL Therapeutics | 16-Sep-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Epsilogen | 09-Sep-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Rhygaze | 17-Jul-2024 | Therapeutic Devices | Pre-Clinical Trials | |||
| Catalym | 16-Jul-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Fore Biotherapeutics | 03-Jul-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 |
Novartis Venture Fund Exits (169)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| TigaTx | 19-Mar-2025 | Merger/Acquisition | |
| ImmPACT Bio | 31-Oct-2024 | ||
| Genedata | 19-Aug-2024 | ||
| Ribon Therapeutics | 05-Aug-2024 | ||
| Aelin Therapeutics | 07-Jul-2023 | ||
| Oculis Holding | 28-Feb-2023 | ||
| Oxagen | 04-Nov-2022 | ||
| EyeSense | 01-Nov-2022 | ||
| Escape Bio | 01-Sep-2022 | Bankruptcy: Liquidation | |
| Forma Therapeutics | 01-Sep-2022 | Merger/Acquisition |
Novartis Venture Fund Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Novartis Venture Fund Co-Investors (180)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Forbion | 8 |
|
|
||
| OrbiMed |
|
|
|||
| BioGeneration Ventures |
|
|
|||
| Johnson & Johnson Innovation - JJDC |
|
|
|||
| SV Health Investors |
|
|
Novartis Venture Fund FAQs
-
What is Novartis Venture Fund?
Founded in 1996, Novartis Venture Fund is a corporate venture capital arm of Novartis based in Basel, Switzerland.
-
When was Novartis Venture Fund founded?
Novartis Venture Fund was founded in 1996.
-
Where is Novartis Venture Fund headquartered?
Novartis Venture Fund is headquartered in Basel, Switzerland.
-
What is Novartis Venture Fund's total asset value?
Novartis Venture Fund has around in total assets under management.
-
How many investments has Novartis Venture Fund made?
Novartis Venture Fund has made 348 investments.
-
What has Novartis Venture Fund invested in?
Novartis Venture Fund has made numerous investments in companies like Alesta Therapeutics, Citryll, and Rhygaze within the Drug Discovery and Therapeutic Devices industries.
-
What has Novartis Venture Fund invested in recently?
Novartis Venture Fund's latest investment was on 19-Dec-2024 in Alesta Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
